AUPR589001A0 - An antibody cancer therapeutic - Google Patents

An antibody cancer therapeutic

Info

Publication number
AUPR589001A0
AUPR589001A0 AUPR5890A AUPR589001A AUPR589001A0 AU PR589001 A0 AUPR589001 A0 AU PR589001A0 AU PR5890 A AUPR5890 A AU PR5890A AU PR589001 A AUPR589001 A AU PR589001A AU PR589001 A0 AUPR589001 A0 AU PR589001A0
Authority
AU
Australia
Prior art keywords
cancer therapeutic
antibody cancer
antibody
therapeutic
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR5890A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intreat Pty Ltd
Original Assignee
Intreat Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreat Pty Ltd filed Critical Intreat Pty Ltd
Priority to AUPR5890A priority Critical patent/AUPR589001A0/en
Publication of AUPR589001A0 publication Critical patent/AUPR589001A0/en
Priority to TW091100845A priority patent/TWI319011B/en
Priority to CNB028050789A priority patent/CN100497385C/en
Priority to PCT/AU2002/000061 priority patent/WO2002057306A1/en
Priority to AT02715313T priority patent/ATE418565T1/en
Priority to ES02715313T priority patent/ES2320421T3/en
Priority to DE60230482T priority patent/DE60230482D1/en
Priority to EP08156593A priority patent/EP1961767B1/en
Priority to DK02715313T priority patent/DK1360203T3/en
Priority to MYPI20020182A priority patent/MY158262A/en
Priority to PT02715313T priority patent/PT1360203E/en
Priority to JP2002558379A priority patent/JP4384852B2/en
Priority to EP02715313A priority patent/EP1360203B1/en
Priority to DK08156593.9T priority patent/DK1961767T3/en
Priority to CA2434490A priority patent/CA2434490C/en
Priority to CN2009101328012A priority patent/CN101555283B/en
Priority to ES08156593T priority patent/ES2383712T3/en
Priority to AT08156593T priority patent/ATE548383T1/en
Priority to US10/622,313 priority patent/US7326415B2/en
Priority to AU2003235005A priority patent/AU2003235005B2/en
Priority to HK05103553.8A priority patent/HK1070903A1/en
Priority to US11/968,607 priority patent/US7531171B2/en
Priority to HK09101899.1A priority patent/HK1123311A1/en
Priority to US12/417,989 priority patent/US7888473B2/en
Priority to JP2009112881A priority patent/JP4457169B2/en
Priority to HK10103195.5A priority patent/HK1138013A1/en
Priority to US12/975,341 priority patent/US8080635B2/en
Priority to US13/298,222 priority patent/US8399617B2/en
Priority to US13/766,630 priority patent/US8709425B2/en
Priority to US14/218,935 priority patent/US20140323693A1/en
Priority to US14/726,391 priority patent/US9663584B2/en
Priority to US15/498,301 priority patent/US10450380B2/en
Priority to US16/568,072 priority patent/US20200071419A1/en
Abandoned legal-status Critical Current

Links

AUPR5890A 2001-01-17 2001-06-22 An antibody cancer therapeutic Abandoned AUPR589001A0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
AUPR5890A AUPR589001A0 (en) 2001-06-22 2001-06-22 An antibody cancer therapeutic
AT02715313T ATE418565T1 (en) 2001-01-17 2002-01-17 ANTIBODIES TO NON-FUNCTIONAL P 2 X 7 RECEPTORS, DIAGNOSIS AND TREATMENT OF CANCER AND OTHER CONDITIONS
ES08156593T ES2383712T3 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
CA2434490A CA2434490C (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
PCT/AU2002/000061 WO2002057306A1 (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
AT08156593T ATE548383T1 (en) 2001-01-17 2002-01-17 DIAGNOSIS AND TREATMENT OF CARCINOMA AND OTHER CONDITIONS
ES02715313T ES2320421T3 (en) 2001-01-17 2002-01-17 ANTIBODIES FOR THE DIAGNOSIS OF A NON-FUNCTIONAL P2X7 RECEIVER AND THE TREATMENT OF CANCER AND OTHER AFFECTIONS.
DE60230482T DE60230482D1 (en) 2001-01-17 2002-01-17 ANTIBODIES TO NON-FUNCTIONAL P 2X7 RECEPTORS, DIAGNOSIS AND TREATMENT OF CANCER AND OTHER SUFFERING
EP08156593A EP1961767B1 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
CNB028050789A CN100497385C (en) 2001-01-17 2002-01-17 Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome
MYPI20020182A MY158262A (en) 2001-01-17 2002-01-17 Diagnosis and treatments of cancers and other conditions
PT02715313T PT1360203E (en) 2001-01-17 2002-01-17 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
JP2002558379A JP4384852B2 (en) 2001-01-17 2002-01-17 Non-functional P2X7 receptor antibody, diagnosis and treatment of cancer and other conditions
EP02715313A EP1360203B1 (en) 2001-01-17 2002-01-17 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
DK08156593.9T DK1961767T3 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other disorders
DK02715313T DK1360203T3 (en) 2001-01-17 2002-01-17 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancer disorders and other conditions
CN2009101328012A CN101555283B (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
TW091100845A TWI319011B (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
US10/622,313 US7326415B2 (en) 2001-01-17 2003-07-17 Antibodies to non-functional P2X7 receptor
AU2003235005A AU2003235005B2 (en) 2001-01-17 2003-08-14 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions
HK05103553.8A HK1070903A1 (en) 2001-01-17 2005-04-26 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
US11/968,607 US7531171B2 (en) 2001-01-17 2008-01-02 Antibodies to non-functional P2X7 receptor
HK09101899.1A HK1123311A1 (en) 2001-01-17 2009-02-27 Diagnosis and treatment of cancers and other conditions
US12/417,989 US7888473B2 (en) 2001-01-17 2009-04-03 Non-functional P2X7 receptor
JP2009112881A JP4457169B2 (en) 2001-01-17 2009-05-07 Diagnosis and treatment of non-functional P2X7 receptor antibodies, cancer and other conditions
HK10103195.5A HK1138013A1 (en) 2001-01-17 2010-03-29 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
US12/975,341 US8080635B2 (en) 2001-01-17 2010-12-21 Non-functional P2X7 receptor
US13/298,222 US8399617B2 (en) 2001-01-17 2011-11-16 Non-functional P2X7 receptor
US13/766,630 US8709425B2 (en) 2001-01-17 2013-02-13 Antibodies to non-functional P2X7 receptor
US14/218,935 US20140323693A1 (en) 2001-01-17 2014-03-18 Antibodies To Non-Functional P2X7 Receptor
US14/726,391 US9663584B2 (en) 2001-01-17 2015-05-29 Antibodies to non-functional P2X7 receptor
US15/498,301 US10450380B2 (en) 2001-01-17 2017-04-26 Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor
US16/568,072 US20200071419A1 (en) 2001-01-17 2019-09-11 Antibodies to non-functional p2x7 receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR5890A AUPR589001A0 (en) 2001-06-22 2001-06-22 An antibody cancer therapeutic

Publications (1)

Publication Number Publication Date
AUPR589001A0 true AUPR589001A0 (en) 2001-07-19

Family

ID=3829859

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR5890A Abandoned AUPR589001A0 (en) 2001-01-17 2001-06-22 An antibody cancer therapeutic

Country Status (1)

Country Link
AU (1) AUPR589001A0 (en)

Similar Documents

Publication Publication Date Title
AUPR395801A0 (en) Antibodies against cancer
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AU2002360766A1 (en) Methods for cancer imaging
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AUPS054702A0 (en) Cancer therapy
AU2002356653A1 (en) Radiotherapy system
AU2002226650A1 (en) Redox therapy for tumors
AU2002365649A1 (en) Anti-dota antibody
AU2003262094A1 (en) Cancer antigen peptide preparation
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002349543A1 (en) Tumor antigens
AU2002353739A1 (en) Therapeutic compounds
AU2002351374A1 (en) Antibodies to treat cancer
AU2002354041A1 (en) Antimnemonic therapy for hypermemory syndromes
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
AU2002335667A1 (en) Modified reoviral therapy
AU2003283339A1 (en) Cancer therapy determination
EP1454914A4 (en) Tumor antigen
AU2001257325A1 (en) Cancer treatment
AU2002351382A1 (en) Combination cancer therapy
EP1403283A4 (en) Tumor antigen
AUPR589001A0 (en) An antibody cancer therapeutic
AU2002306319A1 (en) Tumor antigen
AU2002363198A1 (en) Tumor antigen
AU2001257168A1 (en) Cancer treatment